All the news Showing 10 of 730 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Sex between men Hepatitis C more stigmatising than HIV: gay men’s attitudes towards hepatitis C reinfection Anon / 13 June 2019 Qualitative research with HIV-positive gay and bisexual men in Australia who had been cured of hepatitis C infection revealed that having hepatitis C was more stigmatising than HIV infection. While being a member ... Hepatocellular carcinoma (HCC) Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended Roger Pebody / 11 June 2019 There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in Western Europe, researchers report in the Journal of Viral Hepatitis.Over years or decades, chronic hepatitis B ... Pan-genotypic regimens France switches to simplified pangenotypic hepatitis C treatment Keith Alcorn / 05 June 2019 French health authorities have recommended that everyone diagnosed with hepatitis C should be treated with a pangenotypic direct-acting antiviral combination by a general practitioner unless they have severe liver disease, coinfection or kidney ... Finance, funding & health economics How much can 'Netflix'-style pricing for hepatitis C drugs save? Keith Alcorn / 03 June 2019 A `Netflix`-style pricing agreement that allows the Australian government to treat an unlimited number of people with hepatitis C for AU$1 billion may result in savings close to US$5 billion, according to ... Testing for hepatitis C What do people who inject drugs think of point-of-care HCV testing? Keith Alcorn / 20 May 2019 Point-of-care testing to diagnose hepatitis C virus (HCV) infection has the potential to eliminate the need for multiple appointments to confirm chronic infection. An oral antibody test can provide a result in ... Treatment for people who use drugs World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Keith Alcorn / 30 April 2019 The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people who inject drugs and people in prisons. In an analysis ... Hepatitis C elimination Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment Keith Alcorn / 24 April 2019 Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing an internationally agreed target set by the World Health Organization, The International Liver Congress ... NAFLD Emricasan misses study endpoint for improving portal hypertension in people with NASH Liz Highleyman / 24 April 2019 The experimental caspase inhibitor emricasan did not meet the statistical threshold for improvement of portal hypertension in people with non-alcoholic steatohepatitis (NASH), but it did appear to have some benefit for those at ... Gastrointestinal problems, nausea and vomiting Faecal transplants improve encephalopathy in people with advanced liver disease Liz Highleyman / 24 April 2019 Faecal microbiota transplantation (FMT), which helps restore a healthy mix of bacteria in the gut, can help reverse brain function impairment in people with liver failure, according to a report at the International ... NAFLD NAFLD a rising cause of liver disease in people with HIV Liz Highleyman / 23 April 2019 Now that hepatitis C can be successfully treated, non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of serious liver problems and liver-related death among people living with HIV in the ... ← First12345...73Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds